We are proud not just of what we do ,but how we do it. Responsibility is a core part of our business strategy. The Group has continued to focus its R&D efforts on new hepatitis, oncology, respiratory system and cardio-cerebral medicines. During the fourth quarter, the Group was granted 9 clinical trial approvals, 9 production approvals, and 6 approvals for Consistency Evaluation, and made 6 clinical trial applications, 4 appli...
We are proud not just of what we do ,but how we do it. Responsibility is a core part of our business strategy. The Group has continued to focus its R&D efforts on new hepatitis, oncology, respiratory system and cardio-cerebral medicines. During the fourth quarter, the Group was granted 9 clinical trial approvals, 9 production approvals, and 6 approvals for Consistency Evaluation, and made 6 clinical trial applications, 4 applications for Consistency Evaluation and 11 production applications. Cumulatively, the Group has obtained 766 invention patent approvals, 23 utility model patents and 90 apparel design patents.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.